| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |